findmyKOL

Scott Portnoy, MD

Basic profile

University of Pittsburgh

ORCIDNone on fileNPI
RegionNatrona Heights, PA · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1991Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Scott Portnoy is an Ophthalmology physician affiliated with University of Pittsburgh. OpenAlex indexes 7 publications with 205 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

205citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2853 Freeport Road
Natrona Heights, PA 15065

Telephone

724-224-4240

Registry record last updated 21 Jul 2010.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    76.5%
    Prostaglandin Analog55.8%
    Latanoprost59%Lumigan36%Travoprost3%Bimatoprost2%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug7.6%
    Bromfenac Sodium89%Prolensa11%
    Part D67 patients

    + 4 more classes in this area

  • Cancer & immunology

    9.8%
    Calcineurin inhibitor9.8%
    Restasis50%Cyclosporine50%
    Part D39 patients
  • Musculoskeletal

    7.4%
    Cyclooxygenase Inhibitor7.4%
    Ketorolac Tromethamine100%
    Part D79 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”